Cargando…

The Efficacy of Cyclophosphamide Combined with Prednisone in Membranous Nephropathy Patients with Different Cytochrome P450 2B6 Gene Polymorphisms and Analysis of Factors Influencing the Efficacy

OBJECTIVE: To investigate the efficacy of cyclophosphamide combined with prednisone in membranous nephropathy (MN) patients with different cytochrome P450 (CYP) 2B6 gene polymorphisms and explore the factors influencing the efficacy. METHODS: We performed a prospective and interventional study inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Min, Lv, Yao, Liu, Haokui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580373/ https://www.ncbi.nlm.nih.gov/pubmed/36277605 http://dx.doi.org/10.2147/DDDT.S373487

Ejemplares similares

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
por: Cortazar, Frank B., et al.
Publicado: (2017)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020)

Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
por: El-Serafi, Ibrahim, et al.
Publicado: (2015)

Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma
por: Wang, Lidan, et al.
Publicado: (2020)

Intronic polymorphisms of cytochromes P450
por: Ingelman-Sundberg, Magnus, et al.
Publicado: (2010)

Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients
por: Seredina, Tatyana A, et al.
Publicado: (2012)

Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone/prednisone: No improvement: case report
Publicado: (2022)

Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide–corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2021)

Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide
por: Kikuchi, Taku, et al.
Publicado: (2017)

Cytochrome P(450) 2D6 polymorphism in eastern Indian population
por: Dhuya, Monalisa, et al.
Publicado: (2020)

Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
por: Lin, Wenshan, et al.
Publicado: (2019)

Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia
por: Shin, Wonsuk, et al.
Publicado: (2021)

Influence of Transmembrane Helix Mutations on Cytochrome P450-Membrane Interactions and Function
por: Mustafa, Ghulam, et al.
Publicado: (2019)

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies
por: Laurencet, F M, et al.
Publicado: (1999)

Prednisone: Lack of efficacy: case report
Publicado: (2021)

Effects of cyclophosphamide combined with prednisone on TNF-α expression in treatment of patients with interstitial lung disease
por: Li, Jun, et al.
Publicado: (2019)

Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
por: Gui, Lin, et al.
Publicado: (2021)

Influence of cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate‐amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar
por: Pernaute-Lau, Leyre, et al.
Publicado: (2021)

Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis
por: Elfaki, Imadeldin, et al.
Publicado: (2018)

Complete remission of coronary vasculitis in Churg–Strauss Syndrome by prednisone and cyclophosphamide
por: Riksen, Niels P., et al.
Publicado: (2010)

Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro
por: Wang, Zhe, et al.
Publicado: (2016)

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study
por: Feng, Xiaomeng, et al.
Publicado: (2021)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Clobetasol/prednisone: Lack of efficacy: case report
Publicado: (2021)

Methylprednisolone/prednisone: Lack of efficacy: case report
Publicado: (2021)

Methylprednisolone/prednisone: Lack of efficacy: case report
Publicado: (2022)

An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase
por: Mukherjee, Goutam, et al.
Publicado: (2021)

The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Teply, Benjamin A., et al.
Publicado: (2015)

The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy
por: Preissner, Sarah C., et al.
Publicado: (2013)

Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related
por: Guttman, Yelena, et al.
Publicado: (2019)

Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis
por: Sen, Alaattin, et al.
Publicado: (2019)

Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia
por: Dzhaubermezov, Murat, et al.
Publicado: (2022)

Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs
por: Daali, Youssef, et al.
Publicado: (2022)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
por: Zou, Honghong, et al.
Publicado: (2019)

Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020)

Association of Polymorphism in Cytochrome P450 2D6 and N-Acetyltransferase-2 with Parkinson’s Disease
por: Singh, Madhu, et al.
Publicado: (2010)

Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study
por: Chen, Shasha, et al.
Publicado: (2020)

The Cytochrome P450 Homepage
por: Nelson, David R
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2jkka1afa7lmv30r7mcqp151d3